OrthoPediatrics Corp (KIDS) stock
KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/308% below fair value
$31.41−0.09 (-0.29%)
Close on Nov 17, 2026Market cap $820.13MP/E –Yield –
OrthoPediatrics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
OrthoPediatrics's ebitda for the twelve months ending Sep 30, 2026 was -$2.15M. For fiscal 2025 it was -$18.12M. The highest annual figure on record is -$4.07M in fiscal 2017.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.12M | – |
| FY2024 | Dec 31, 2024 | -$15.93M | – |
| FY2023 | Dec 31, 2023 | -$9.37M | – |
| FY2022 | Dec 31, 2022 | -$12.30M | – |
| FY2021 | Dec 31, 2021 | -$7.34M | – |
| FY2020 | Dec 31, 2020 | -$18.75M | – |
| FY2019 | Dec 31, 2019 | -$4.41M | – |
| FY2018 | Dec 31, 2018 | -$6.66M | – |
| FY2017 | Dec 31, 2017 | -$4.07M | – |
| FY2016 | Dec 31, 2016 | -$4.23M | – |
| FY2015 | Dec 31, 2015 | -$4.74M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.40M | – |
| Q2 FY2026 | Jun 30, 2026 | $1.64M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.61M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.13M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.49M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.93M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$286.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$887.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.70M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.88M | – |
| Q3 FY2023 | Sep 30, 2023 | -$238.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.51M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.74M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.79M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.67M | – |
| Q2 FY2022 | Jun 30, 2022 | -$412.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.43M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.75M | – |
| Q3 FY2021 | Sep 30, 2021 | -$921.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$238.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.43M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.43M | – |
| Q3 FY2020 | Sep 30, 2020 | -$87.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.11M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.12M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.62M | – |
| Q3 FY2019 | Sep 30, 2019 | -$193.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$706.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.89M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.15M | – |
| Q3 FY2018 | Sep 30, 2018 | -$395.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.40M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.71M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.55M | – |
| Q3 FY2017 | Sep 30, 2017 | -$98.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$83.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$339.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.75M | – |
See a number that looks wrong?